04 March 2023 : Clinical Research
Perfusate Neutrophil Gelatinase-Associated Lipocalin, Kidney Injury Molecular-1, Liver-Type Fatty Acid Binding Protein, and Interleukin-18 as Potential Biomarkers to Predict Delayed Graft Function and Long-Term Prognosis in Kidney Transplant Recipients: A Single-Center Retrospective Study
Zejia Sun1AEF, Zihao Gao1ACE, Xin Li1ABC, Xiang Zheng1BD, Wei Wang1AEG*, Peng Qiao1AEFDOI: 10.12659/MSM.938758
Med Sci Monit 2023; 29:e938758
Table 2 Comparison of perfusate kidney injury biomarker levels between patients diagnosed with DGF and NON-DGF.
| Biomarker | DGF (n=14) | NON-DGF (n=88) | P valuea |
|---|---|---|---|
| NGAL (ng/ml) | 203.67±44.27 | 147.03±40.34 | <0.001 |
| L-FABP (ng/ml) | 2153.33±1467.10 | 1987.84±1387.54 | 0.682 |
| KIM-1 (ng/ml) | 190.86±42.94 | 135.27±39.38 | <0.001 |
| IL-18 (pg/ml) | 278.48±153.37 | 241.04±171.47 | 0.444 |
| Values are given as mean±SD. a test. NGAL – neutrophil gelatinase-associated lipocalin; L-FABP – liver-type fatty acid binding protein; KIM-1 – kidney injury molecular-1; IL-18 – interleukin-18; DGF – delayed graft function; OR – odds ratio. | |||